ABSTRACT
Neuroblastoma is the most common extracranial solid malignant tumor of childhood. It has a spectrum of locations and degrees of histopathologic differentiation resulting in a diversity of clinical and biologic features ( 1-3 ). With the exception of infants under the age of one year, the prognosis of children with neuroblastoma is generally poor. Tumor stage is an extremely important indicator of patient outcome and imaging therefore plays a crucial role in the determination of stage prior to treatment.
